6ST4 image
Entry Detail
PDB ID:
6ST4
Keywords:
Title:
Crystal structure of the tick chemokine-binding protein Evasin-4 (SG 1)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-09-10
Release Date:
2020-09-02
Method Details:
Experimental Method:
Resolution:
1.29 Å
R-Value Free:
0.19
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Evasin-4
Chain IDs:A
Chain Length:104
Number of Molecules:1
Biological Source:Rhipicephalus sanguineus
Primary Citation
Structural characterization of anti-CCL5 activity of the tick salivary protein evasin-4.
J.Biol.Chem. 295 14367 14378 (2020)
PMID: 32817341 DOI: 10.1074/jbc.RA120.013891

Abstact

Ticks, as blood-sucking parasites, have developed a complex strategy to evade and suppress host immune responses during feeding. The crucial part of this strategy is expression of a broad family of salivary proteins, called Evasins, to neutralize chemokines responsible for cell trafficking and recruitment. However, structural information about Evasins is still scarce, and little is known about the structural determinants of their binding mechanism to chemokines. Here, we studied the structurally uncharacterized Evasin-4, which neutralizes a broad range of CC-motif chemokines, including the chemokine CC-motif ligand 5 (CCL5) involved in atherogenesis. Crystal structures of Evasin-4 and E66S CCL5, an obligatory dimeric variant of CCL5, were determined to a resolution of 1.3-1.8 Å. The Evasin-4 crystal structure revealed an L-shaped architecture formed by an N- and C-terminal subdomain consisting of eight β-strands and an α-helix that adopts a substantially different position compared with closely related Evasin-1. Further investigation into E66S CCL5-Evasin-4 complex formation with NMR spectroscopy showed that residues of the N terminus are involved in binding to CCL5. The peptide derived from the N-terminal region of Evasin-4 possessed nanomolar affinity to CCL5 and inhibited CCL5 activity in monocyte migration assays. This suggests that Evasin-4 derivatives could be used as a starting point for the development of anti-inflammatory drugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures